Detection of Anti-Infliximab Antibodies Is Impacted by Antibody Titer, Infliximab Level and IgG4 Antibodies: A Systematic Comparison of Three Different Assays

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756283x16658223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

PWE-109 Measurement of Infliximab and Anti-Infliximab Antibodies - Analytical Aspects and Clinical Implications: Abstract PWE-109 Table

Gut
Gastroenterology
2013English

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2014English

Infliximab (Anti–Tumor Necrosis Factor Α Antibody)

Archives of Dermatology
2001English

Detection of Anti-Hla Antibodies by Flow Cytometer

2016English

SAT0152 Real-Life Infliximab and Adalimumab Trough Level and Anti-Drug Antibody Measurements in Rheumatology: The Finnish Experience

2017English

A Dermatomyositis and Scleroderma Overlap Syndrome With a Remarkable High Titer of Anti-Exosome Antibodies

Reumatismo
Rheumatology
2011English

Correlation Between Elevation of Serum Antinuclear Antibody Titer and Decreased Therapeutic Efficacy in the Treatment of Behçet’s Disease With Infliximab

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2012English

Suppression of Anti-Drug Antibodies to Infliximab or Adalimumab With the Addition of an Immunomodulator in Patients With Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

IgG4 Antibodies and Cancer-Associated Inflammation

OncoImmunology
OncologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy